Upregulated expression of LncRNA nicotinamide nucleotide transhydrogenase antisense RNA 1 is correlated with unfavorable clinical outcomes in cancers
Abstract Background The nicotinamide nucleotide transhydrogenase antisense RNA 1 (NNT-AS1) is a long non-coding RNA aberrantly expressed in human malignancies. We aimed to analyze available data to evaluate the correlation between NNT-AS1 expression and cancer prognosis. Methods Literature retrieval...
Main Authors: | Chenghao Zhang, Xiaolei Ren, Zhongyue Liu, Chao Tu |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2020-09-01
|
Series: | BMC Cancer |
Subjects: | |
Online Access: | http://link.springer.com/article/10.1186/s12885-020-07348-5 |
Similar Items
-
Transcription Levels of nicotinamide nucleotide transhydrogenase and Its Antisense in Breast Cancer Samples
by: Soraya Saleh Gargari, et al.
Published: (2019-06-01) -
Nicotinamide nucleotide transhydrogenase (NNT) regulates mitochondrial ROS and endothelial dysfunction in response to angiotensin II
by: K.N. Shashanka Rao, et al.
Published: (2020-09-01) -
Long non-coding RNA NNT-AS1 functions as an oncogenic gene through modulating miR-485/BCL9 in cholangiocarcinoma
by: Huang L, et al.
Published: (2019-08-01) -
The Role of Long Non-Coding RNA NNT-AS1 in Neoplastic Disease
by: Cong Zhou, et al.
Published: (2020-10-01) -
Loss of Nicotinamide nucleotide transhydrogenase sensitizes embryos to ethanol-induced neural crest and neural apoptosis via generation of reactive oxygen species
by: Rayna Mazumdar, et al.
Published: (2023-06-01)